Investigation of transcription factor AP-2 beta genotype in women with premenstrual dysphoric disorder.

@article{Damberg2005InvestigationOT,
  title={Investigation of transcription factor AP-2 beta genotype in women with premenstrual dysphoric disorder.},
  author={Mattias Damberg and Lars Westberg and Cecilia Bergg{\aa}rd and Mikael Land{\'e}n and Charlotta Sundblad and Olle Eriksson and Tord Naess{\'e}n and Agneta Ekman and Elias Eriksson},
  journal={Neuroscience letters},
  year={2005},
  volume={377 1},
  pages={49-52}
}
It has repeatedly been shown that the serotonergic system is involved in the symptomatology of premenstrual dysphoric disorder (PMDD). Women with PMDD are reported to differ from symptom-free controls with regard to serotonin-related biological markers. Evidence from family and twin studies suggests a genetic contribution to the aetiology of PMDD. The expression of human transcription factor AP-2beta in neural crest cell lineages and neuroectodermal cells suggests that this protein may be of… CONTINUE READING

Citations

Publications citing this paper.
Showing 1-8 of 8 extracted citations

Similar Papers

Loading similar papers…